Best in Biotech 19 Mar 2024
The 9 hottest private biotech companies in San Diego
Discover nine visionary biotech companies headquartered in San Diego, which is one of the biggest biotech hubs in the US.
Search Results for: Humanized antibody
2024 biotech deals tracker: the latest partnerships and M&A
Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical companies and by month. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you stay informed about the most significant trends and strategic moves shaping the industry. Would you like to receive […]
In Depth 15 Feb 2024
Turning the tide: recent advancements in childhood cancer research
As we observe International Childhood Cancer Day today, let us take a look at some of the recent advancements in childhood cancer research.
Best in Biotech 6 Feb 2024
16 UK biotech companies you should know about
Take a closer look at 16 of the top U.K. biotech companies, as the nation’s biotech scene is now one of the most vibrant in Europe.
ADVERTISEMENT
Best in Biotech 30 Jan 2024
Navigating German biotech: 13 key players to know
The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies.
Best in Biotech 23 Jan 2024
19 French biotechs you should know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 19 top French biotech companies!
Best in Biotech 22 Jan 2024
Eight newly approved drugs that could become blockbusters in 2024
The much-awaited Drugs to Watch list by Clarivate is out. Let’s do a deep dive into the therapies that made the cut in 2024.
Best in Biotech 19 Dec 2023
Nine biotech companies to watch in 2024
2024 is shaping up to be an exciting year for the industry. Discover nine biotech companies to keep an eye on in 2024.
In Depth 9 Aug 2023
Meet the startup working to help treat a rare pediatric cancer
Nearly 50% of the children diagnosed with neuroblastoma are considered high-risk, where the tumor has spread, making surgery no longer a viable treatment option. Owing to this stark statistic, the disease is quite difficult to treat. But there might be light at the end of the tunnel. U.K.-based Renaissance Pharma’s drug candidate, which has shown […]
In Depth 24 Jul 2023
Sarcoma research: is a breakthrough in sight?
Among the rarest forms of cancers, sarcomas develop in the bones and connective tissues that support structures in the body like blood vessels, nerves and joints. This year, around 13,400 new cases of soft tissue sarcomas are estimated to be diagnosed in the U.S. alone, according to the American Cancer Society. As July marks Sarcoma […]
News and Trends 7 Jul 2023
FDA approves Alzheimer’s treatment
Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) supporting the traditional approval of LEQEMBI (lecanemab-irmb) 100 mg/mL injection for intravenous use. The decision makes LEQEMBI the first and only approved treatment shown to reduce the rate of disease progression […]
News and Trends 27 Jun 2023
UCB myasthenia gravis drug given FDA approval
UCB has announced RYSTIGGO (rozanolixizumab-noli) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. Rozanolixizumab-noli injection for subcutaneous infusion is a humanized IgG4 monoclonal antibody that binds to the neonatal […]